Acetic Acid

Acetic Acid

SCHEMBL5046683

CC(=O)O.NCc1ncc(C(F)(F)F)cc1Cl

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
AGBL2 Q5U5Z8 1/20 0.52
ALDH1A1 P00352 5/20 0.52
HTT P42858 1/20 0.52
RAB9A P51151 1/20 0.52
GLA P06280 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MAPT P10636 1/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL28417972 0.99 KMT2A (0.54) KMT2AMEN1NPSR1AGBL2ALDH1A1
Acetic Acid SCHEMBL28393632 0.92 KMT2A (0.53) KMT2AMEN1NPSR1AGBL2ALDH1A1
SCHEMBL31255260 0.89 TDP1 (0.58) KMT2AMEN1NPSR1ALDH1A1HTT
SCHEMBL635541 0.89 TDP1 (0.58) KMT2AMEN1NPSR1ALDH1A1HTT
Acetic Acid SCHEMBL4444086 0.89 KMT2A (0.53) KMT2AMEN1NPSR1AGBL2ALDH1A1
Hydrochloric Acid SCHEMBL6157878 0.88 TDP1 (0.56) KMT2AMEN1NPSR1ALDH1A1HTT
Hydrochloric Acid SCHEMBL637924 0.88 TDP1 (0.56) KMT2AMEN1NPSR1ALDH1A1HTT
Hydrochloric Acid SCHEMBL16165936 0.88 TDP1 (0.56) KMT2AMEN1NPSR1ALDH1A1HTT
Sulfuric Acid SCHEMBL18191278 0.87 KMT2A (0.56) KMT2AMEN1NPSR1ALDH1A1HTT
Water SCHEMBL28174658 0.86 TDP1 (0.55) KMT2AMEN1NPSR1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114478365-A Purification method of 2-aminomethyl-3-chloro-5-trifluoromethylpyridine acetate 大连九信作物科学有限公司 2022-05-13 CN claimed
CN-111170934-B Dissociation method of 2-aminomethyl-3-chloro-5-trifluoromethyl pyridine nickel acetate complex 大连九信精细化工有限公司 2021-07-13 CN claimed
CN-111170934-A Dissociation method of 2-aminomethyl-3-chloro-5-trifluoromethyl pyridine nickel acetate complex 大连九信精细化工有限公司 2020-05-19 CN claimed
CN-111138351-A Synthetic method of 2-aminomethyl-3-chloro-5-trifluoromethylpyridine acetate 大连九信精细化工有限公司 2020-05-12 CN claimed
CN-111372919-B Method for preparing fluopicolide 拜耳公司 2024-07-16 CN disclosed
CN-115784976-A Improved preparation method of fluopicolide 武威广达科技有限公司 2023-03-14 CN disclosed
CN-114478365-A Purification method of 2-aminomethyl-3-chloro-5-trifluoromethylpyridine acetate 大连九信作物科学有限公司 2022-05-13 CN disclosed
CN-114478365-A Purification method of 2-aminomethyl-3-chloro-5-trifluoromethylpyridine acetate 大连九信作物科学有限公司 2022-05-13 CN disclosed
CN-114478365-A Purification method of 2-aminomethyl-3-chloro-5-trifluoromethylpyridine acetate 大连九信作物科学有限公司 2022-05-13 CN disclosed
US-11130735-B2 Process for the preparation of fluopicolide BAYER AKTIENGESELLSCHAFT 2021-09-28 US disclosed
CN-111170934-B Dissociation method of 2-aminomethyl-3-chloro-5-trifluoromethyl pyridine nickel acetate complex 大连九信精细化工有限公司 2021-07-13 CN disclosed
US-20200283388-A1 PROCESS FOR THE PREPARATION OF FLUOPICOLIDE BAYER AKTIENGESELLSCHAFT (DE) 2020-09-10 US disclosed
CN-111138351-A Synthetic method of 2-aminomethyl-3-chloro-5-trifluoromethylpyridine acetate 大连九信精细化工有限公司 2020-05-12 CN disclosed
EP-3489221-A1 PROCESS FOR THE PREPARATION OF FLUOPICOLIDE Bayer AG (DE) 2019-05-29 EP disclosed
US-7456290-B2 Process for the preparation of 2-aminomethylpyridine derivative BAYER CROPSCIENCE S.A. (FR) 2008-11-25 US disclosed
EP-1565440-B1 NOVEL PROCESS FOR THE PREPARATION OF 2-AMINOMETHYLPYRIDINE DERIVATIVE BAYER CROPSCIENCE SA (FR) 2006-12-20 EP disclosed
US-20060004206-A1 Novel process for the preparation of 2-aminomethylpyridine derivative BAYER CROPSCIENCE S.A. (FR) 2006-01-05 US disclosed
EP-1565440-A1 NOVEL PROCESS FOR THE PREPARATION OF 2-AMINOMETHYLPYRIDINE DERIVATIVE Bayer CropScience S.A. (FR) 2005-08-24 EP disclosed
WO-2004046114-A1 NOVEL PROCESS FOR THE PREPARATION OF 2-AMINOMETHYLPYRIDINE DERIVATIVE BAYER CROPSCIENCE S.A. (FR) 2004-06-03 WO disclosed
EP-1422221-A1 Novel process for the preparation of 2-aminomethylpyridine derivative Bayer CropScience SA (FR) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004206-A1 Novel process for the preparation of 2-aminomethylpyridine derivative AZI2, IL4I1, ABL2 KMT2A 457/4885MEN1 2177/4885NPSR1 1747/4885
US-11130735-B2 Process for the preparation of fluopicolide HCN4, KCNJ1, CYP51A1 KMT2A 1500/4885MEN1 3049/4885NPSR1 2335/4885
US-20200283388-A1 PROCESS FOR THE PREPARATION OF FLUOPICOLIDE HCN4, KCNJ1, CYP51A1 KMT2A 1500/4885MEN1 3049/4885NPSR1 2335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.